Holly Whittemore
Comptroller/Controller/Auditor at Nimbus Therapeutics LLC
Profile
Holly Whittemore is currently working as the Chief Accounting Officer at Nimbus Therapeutics LLC.
Previously, she worked as the Director of Finance at Atlas Venture Advisors, Inc. and as a Principal at Coopers & Lybrand LLP.
She completed her undergraduate degree at the University of Virginia.
Holly Whittemore active positions
| Companies | Position | Start |
|---|---|---|
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Comptroller/Controller/Auditor | 2021-09-20 |
Former positions of Holly Whittemore
| Companies | Position | End |
|---|---|---|
| Coopers & Lybrand LLP | Corporate Officer/Principal | - |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Director of Finance/CFO | - |
Training of Holly Whittemore
| University of Virginia | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Health Technology |
| Coopers & Lybrand LLP | Commercial Services |
- Stock Market
- Insiders
- Holly Whittemore
